Abstract: An organic light emitting diode display device includes: a substrate; a first antireflection line formed on the substrate and including a first metallic layer and a first inorganic layer stacked sequentially; a gate line formed on the first antireflection line; a gate insulation layer formed on the substrate and the gate line; a second antireflection line formed on the gate insulation layer and including a second metallic layer and a second inorganic layer stacked sequentially; a data line formed on the second antireflection line; and wherein the first inorganic layer connects the first metallic layer and the gate line electrically and the second inorganic layer connects the second metallic layer and the data line.

Abstract: A method of fabricating an organic light emitting display device includes forming a first electrode in both a luminescent region and a part of a non-luminescent region, forming a buffer layer in the non-luminescent region, forming an insulation pattern on the buffer layer in the non-luminescent region, forming an auxiliary electrode on the insulation pattern in the non-luminescent region, forming an organic emission layer in both the luminescent region and the non-luminescent region, forming a second electrode in both the luminescent region and the non-luminescent region, and applying over-voltage to the auxiliary electrode, the organic emission layer on the auxiliary electrode and the second electrode.

Abstract: An organic light emitting diode display device includes a substrate; an antireflection layer on a first surface of the substrate and including a metallic layer and an insulating layer; a driving element portion on the antireflection layer and including thin film transistors and metallic lines; and an organic light emitting portion driven by the driving element portion.

Abstract: A method of fabricating an organic light emitting display device includes forming a first electrode in both a luminescent region and a part of a non-luminescent region, forming a buffer layer in the non-luminescent region, forming an insulation pattern on the buffer layer in the non-luminescent region, forming an auxiliary electrode on the insulation pattern in the non-luminescent region, forming an organic emission layer in both the luminescent region and the non-luminescent region, forming a second electrode in both the luminescent region and the non-luminescent region, and applying over-voltage to the auxiliary electrode, the organic emission layer on the auxiliary electrode and the second electrode.

Abstract: The present invention involves a new functional dietary fiber supplement for intestinal health. Unlike conventional products made of plain psyllium husks, the xylitol coating makes oral consumption very convenient. The ground psyllium husk used in this invention is exceptionally effective at facilitating intestinal functions and increasing feces volume. The refreshing flavor of xylitol shields the original smell of psyllium and enhances the product so that it corresponds well with modern taste. When consumed properly, this invention can contribute much to the maintenance of a healthy digestive tract.

Abstract: The present invention relates to a therapeutic agent for ischemia which inhibits apoptosis under ischemic condition. The therapeutic agent of the present invention comprises antibacterial agents of quinolones, quinones, aminoglycosides or chloramphenicol as an active ingredient. Since the invented therapeutic agent improved the viability of cells under hypoxic and hypoglycemic condition, it can be clinically for ischemic diseases such as applied as a potential drug for ischemia-associated infarction and cerebral infarction.

Abstract: The present invention relates to a method for inhibiting apoptosis under ischemic condition, which comprises a step of administering antibiotics of quinolones, quinones, aminoglycosides or chloramphenicol to an individual under ischemic condition which lacks an adequate supply of oxygen and glucose. In accordance with the present invention, the antibiotics increase cell viability under hypoxic and hypoglycemic condition, assuring that they can be applied as a therapeutic agent for ischemia-associated diseases such as myocardial infarction and cerebral infarction.

Abstract: The present invention relates to a therapeutic agent for ischemia which inhibits apoptosis under ischemic condition. The therapeutic agent of present invention comprises antibacterial agents of quinolones, quinones, aminoglycosides or chlorampheni-col as an active ingredient. Since the invented therapeutic agent improved the viability of cells under hypoxic and hypoglycemic condition, it can be clinically for ischemic diseases such as applied as a potentiad drug for ischemia-associated infarction and cerebral infarction.